What was Meribank Biotech Co Ltd’s price range in the past 12 months?
Meribank Biotech Co Ltd lowest stock price was TWD 7.94 and its highest was TWD 17.45 in the past 12 months.
What is Meribank Biotech Co Ltd’s market cap?
Meribank Biotech Co Ltd’s market cap is TWD 852.27M.
When is Meribank Biotech Co Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Meribank Biotech Co Ltd overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Meribank Biotech Co Ltd pay dividends?
Meribank Biotech Co Ltd does not currently pay dividends.
What is Meribank Biotech Co Ltd’s EPS estimate?
Meribank Biotech Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Meribank Biotech Co Ltd have?
Meribank Biotech Co Ltd has 95,976,400 shares outstanding.
Which hedge fund is a major shareholder of Meribank Biotech Co Ltd?
Currently, no hedge funds are holding shares in TW:4724
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Meribank Biotech Co Ltd
Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various cell types, including mesenchymal stem cells sourced from the placenta and umbilical cord, hematopoietic stem cells from cord blood, and diverse immune cells. Additionally, Meribank is involved in developing advanced cellular cryopreservation protocols and provides postpartum nursing services.